1Latini R, Stassewsky L. Benificial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling n patients with large acute myocardial infarction:the Delapril Remodeling after Acute Myocardial Infarction (DRAMI
2Progress collaborative groap. Randomized trial of a perindoprilbased bolld-pressure-lowering regimen among 6,105 individuals with previons stroke or transient ischemic attack [ J ]. Lancet,2001,358(9287) :1033-1041.
3Wang CH,Lapointe N,?,et al. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increase myocardial glucose uptake in Zucker fatty rats: studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor,and an
4Preston RA. Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type Ⅱ diabetes mellitus. J Clin Pharmaco1,2002,42 (7) :754-761.
5Nagashina H. An angiotensin-converting enzyme inhibitor, not an angiotensin Ⅱ type- Ⅰ receptor blocker prevents beta-aminopropionitrile monofumarate a-induced aortic dissection in rats. J Vasc Surg,2002,36(4) :818-823.
6Gaddam V. ACE inhibitors in cardiovascular disease. J Ark Med Soc,2002,98 (10) :328-329.
7Banach T. The effect of the year-ACEI intake on cardian heart rate variability in patients with primary hypertention. Folia Med Cracur,2001,42 (3): 129-140.
8Liu YH,Xu J. Effect of ACEI and ARB on endothelial No synthase knockout mice with heart failure. Hypertention ,2002,39(2) :375-381.
9Kula S. Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to ACEI. Can J Cardiol, 2003, 19(4) :405-408.
10Heudi O. Investigation of bradykinin metabolism in human and rat plasma in the presense of the dual ACE/NEP inhibitors GW660511X and omapatrilat. J Pept Sci,2002,8 (11) ,591-600.
